BDA-366

Item number	Size	Delivery time	Price
TGM-T6778-1mg	1 mg	7 - 10 business days*	46.00€
TGM-T6778-5mg	5 mg	7 - 10 business days*	108.00€
TGM-T6778-10mg	10 mg	7 - 10 business days*	186.00€
TGM-T6778-25mg	25 mg	7 - 10 business days*	311.00€
TGM-T6778-50mg	50 mg	7 - 10 business days*	453.00€
TGM-T6778-100mg	100 mg	7 - 10 business days*	635.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BDA-366, a potent Bcl2 antagonist, selectively binds the Bcl2-BH4 domain with high... more

Close menu

Product information "BDA-366"

Description: BDA-366, a potent Bcl2 antagonist, selectively binds the Bcl2-BH4 domain with high affinity (Ki = 3.3 nM), inducing a conformational change that nullifies its antiapoptotic function, thereby transforming it into a pro-apoptotic entity. This compound effectively suppresses lung cancer cell growth[1]. Target: BCL. Smiles: CCN(CC)C[C@H](CNc(c(C(c1c2cccc1)=O)c1C2=O)ccc1NC[C@@H]1OC1)O

Supplier:	TargetMol
Supplier-Nr:	T6778

Properties

Application:	Bcl2-BH4 domain antagonist
MW:	423.5 D
Formula:	C24H29N3O4

Database Information

CAS :	1909226-00-1\| Matching products
KEGG ID :	K02161 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BDA-366"

Write a review